Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3776764015 | Risankizumab only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3776765019 | Product containing only risankizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4571941000052113 | läkemedel som endast innehåller risankizumab, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Risankizumab only product in parenteral dose form | Is a | Risankizumab-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Risankizumab only product in parenteral dose form | Is a | Risankizumab only product | true | Inferred relationship | Some | ||
| Risankizumab only product in parenteral dose form | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Risankizumab only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Risankizumab only product in parenteral dose form | Has active ingredient | Risankizumab | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Risankizumab 150 mg/mL solution for injection | Is a | True | Risankizumab only product in parenteral dose form | Inferred relationship | Some | |
| Product containing precisely risankizumab 90.361 milligram/1 milliliter conventional release solution for injection (clinical drug) | Is a | True | Risankizumab only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR